NCT02278094

Brief Summary

Background: OSAS is a type of sleep disorder characterized by intermittent, partial or complete upper airway (UA) collapse, seriously impacting sleep apnea and respiratory insufficiency. The major upper airway dilator muscle (genioglossus) is more active during periods of stable breathing compared with periods of cyclical breathing when obstructive apneas occurred. UA muscle strength is linearly related to the inspiratory pump muscle strength. The ratios of UA muscle strength (tongue protrusion, TP) and inspiratory pump muscle strength (PImax) were not different between individuals with and without OSAS. However, a highly wakeful ratio of TP force to PImax appears to be associated with a reduced propensity to moderate-to-severe OSAS. Up to 95% of OSAS cases are treated with continuous positive airway pressure (CPAP), which is the most effective, commonly used, and low-risk treatment method. However, patients using CPAP therapy could face ongoing difficulties. Aims: To evaluate the effects of home-based exercise for patients with moderate to severe OSAS. This study was a randomized clinical trial conducted at three different intervention protocols as experimental groups. We will use cluster random sampling assign to each group. CPAP treatment group will be the control group. Methods: Subject above 20 years old will be diagnosed to moderate and severe OSAS. Subjects will be assign to walking exercise (WE), Threshold Inspiratory Muscle Trainer (TIMT) and Tongue Muscle Trainer (TMT) treatment groups. We will compare the Polysomnography (PSG) data, Epworth Sleepiness scale (ESS), World Health Organization Quality of Life( WHOQOL) questionnaire is a shorter version of the original instrument (WHOQOL-BREF), 6-minute walking test (6MWD), rate of perceived exertion scale (RPE), flow-volume loop (FV-Loop), tongue and grasp muscle strength, anthropometric data and daily note at baseline, 3 months (end-of-intervention) and 6 months (post intervention follow-up) in patients with moderate to severe OSAS. They will undergo three months of the home-based exercises. Patients will be followed up with weekly telephone calls and be interviewed monthly. Expected results: By using the WE, TIMT and TMT therapies, the airway collapse during sleep will be prevented when the whole body muscle strength, inspiratory pump muscle strength and tongue muscle strength are enhanced.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

September 28, 2014

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 29, 2014

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
Last Updated

March 22, 2024

Status Verified

March 1, 2024

Enrollment Period

5.7 years

First QC Date

September 28, 2014

Last Update Submit

March 20, 2024

Conditions

Keywords

OSASAdultHome-basedGenioglossusInspiratory muscleExercise

Outcome Measures

Primary Outcomes (1)

  • Polysomnography(PSG) data in the scoring of apnea-hypopnea index (AHI), sleep stages and respiratory events.

    The sleep efficacy will be calculated by the parameters of PSG.

    Baseline, post-intervention (3 months) and post-intervention follow (6 months after ceasation of intervention)

Secondary Outcomes (7)

  • Epworth Sleepiness Score (ESS)

    Baseline, post-intervention (3 months) and post-intervention follow (6 months after ceasation of intervention)

  • WHOQOL-BREF(EQ-5D) questionnaire

    Baseline , post-intervention (3 months) and post-intervention follow (6 months after ceasation of intervention)

  • 6MWD( = 6MWT)

    Baseline, post-intervention (3 months) and post-intervention follow (6 months after ceasation of intervention)

  • RPE

    Baseline, post-intervention (3 months) and post-intervention follow (6 months after ceasation of intervention)

  • Flow-volume loop (FV-Loop)

    Baseline, post-intervention (3 months) and post-intervention follow (6 months after ceasation of intervention)

  • +2 more secondary outcomes

Study Arms (2)

Experimental group

EXPERIMENTAL

Subjects will be in random cluster assign to walking exercise (WE), Threshold Inspiratory Muscle Trainer (TIMT) and Tongue Muscle Trainer (TMT) treatment groups.

Device: Tongue Muscle Trainer (TMT)Device: Threshold Inspiratory Muscle Trainer (TIMT)Procedure: Walking Exercise

Control group

ACTIVE COMPARATOR

Up to 95% of OSAS cases are treated with continuous positive airway pressure (CPAP), CPAP treatment group will be the control group.

Device: Continuous Positive Airway Pressure (CPAP)

Interventions

Subject will be instructed to compress the Iowa Oral Performance Instrument (IOPI) IOPI's bulb using tongue in three directions (anterior and both lateral sides). Then, hold 30-35 seconds each time. Subjects will be encouraged to do 60 minutes of exercise daily then continue three to five times a week for a total of 3 months.

Experimental group

Resistance of the TIMT devices will be set from 30% of the maximum inspiratory pressure. Nose clip follow by normal breathing. Seal the mouth to the device's mouth piece then inhale through the device. Subjects will be encouraged to do 60 minutes of exercise daily then continue three to five times a week for a total of 3 months.

Experimental group

Subjects will be encouraged to perform walking exercise in the field 10000 steps/ 60 minutes daily then continue three to five times a week during first months. Followed by 12500 steps and 15000steps per day during the second and third months.

Experimental group

CPAP regular therapy per day (use ≥ 4 h/day) then continue three to five times a week for a total of 3 months.

Control group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mean aged ≥20 years old,
  • Good general health (stability of clinic state)
  • Epworth Sleepiness Scale ≥ 10
  • PSG for discriminate moderate to severe subjects (AHI≧15 h-1)
  • Presence of excessive daytime somnolence (EDS)
  • From the community and hospital

You may not qualify if:

  • Inability to exercise
  • Exercise-induced myocardial ischemia
  • Chronic pulmonary disease
  • Stroke
  • Peripheral arterial disease
  • Severe psychiatric disorder (e.g. bipolar disorder, schizophrenia)
  • Tensile hypertrophy
  • Pregnancy
  • Alcoholism (≥ 50 gm per day)
  • Active or uncontrolled chronic medical condition (e.g., cardio-respiratory disease, diabetes mellitus, endocrine disorders, stroke, abnormal pulmonary function, morbid obesity, renal disease, hypertension (i.e., \>159/99 mm Hg), myopathy, neurologic illness, recent infection , and recent (\< 3 months) myocardial infarction, or angina).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tainan Hospital (Ministry of Health and Welfare)

Tainan, 70043, Taiwan

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructiveMotor Activity

Interventions

Continuous Positive Airway Pressure

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Hung Ching-Hsia, PT

    National Cheng Kung University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2014

First Posted

October 29, 2014

Study Start

September 1, 2014

Primary Completion

May 1, 2020

Study Completion

August 1, 2020

Last Updated

March 22, 2024

Record last verified: 2024-03

Locations